JAMA Intern Med:学历越高,心血管病风险越低

2017-06-15 许菁 中国循环杂志

近日,美国发布的一项研究显示,对于中年人,不管社会经济地位如何,随着每个人接受的学校教育水平升高,其终生(45-85岁)心血管病风险逐渐降低。

近日,美国发布的一项研究显示,对于中年人,不管社会经济地位如何,随着每个人接受的学校教育水平升高,其终生(45-85岁)心血管病风险逐渐降低。


在低于高中学历的人群中,50%以上的人在其一生中会发生心血管事件。而最高教育水平者的终生心血管病风险较最低学历者降低20%。

而近期国内研究发现,我国居民受教育程度越低,代谢综合征发病风险越高。受教育程度越低的人,则越嗜好吸烟或饮酒。

因此,受教育水平可能通过影响人们的健康知识、生活方式、饮食习惯进而影响人群的健康。受教育程度较高者有能力获得更多的健康相关知识,更关注自身的健康,倾向于选择健康的生活方式和饮食习惯。

研究纳入了13948名45~64岁的受试者,随访269210人年,发生了4512例心血管事件和2401非心血管死亡。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644562, encodeId=600e1644562d0, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Apr 11 14:30:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607649, encodeId=f52f160e6496a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jun 17 00:30:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211314, encodeId=cbfb2113144a, content=也不绝对是, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Fri Jun 16 05:48:30 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211132, encodeId=c10721113260, content=感谢分享!继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Jun 15 14:16:43 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211110, encodeId=36e621111049, content=所谓的,知识越丰富的人,越懂得养生, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KzSbouu359pgvYDCyAK5ibibTnaLHroP5qfFyvQgWlYFsrDGc3G5hialGftuXhkCvibDCf490Hey7JLB/0, createdBy=de201996268, createdName=月叔, createdTime=Thu Jun 15 13:05:52 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644562, encodeId=600e1644562d0, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Apr 11 14:30:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607649, encodeId=f52f160e6496a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jun 17 00:30:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211314, encodeId=cbfb2113144a, content=也不绝对是, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Fri Jun 16 05:48:30 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211132, encodeId=c10721113260, content=感谢分享!继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Jun 15 14:16:43 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211110, encodeId=36e621111049, content=所谓的,知识越丰富的人,越懂得养生, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KzSbouu359pgvYDCyAK5ibibTnaLHroP5qfFyvQgWlYFsrDGc3G5hialGftuXhkCvibDCf490Hey7JLB/0, createdBy=de201996268, createdName=月叔, createdTime=Thu Jun 15 13:05:52 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644562, encodeId=600e1644562d0, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Apr 11 14:30:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607649, encodeId=f52f160e6496a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jun 17 00:30:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211314, encodeId=cbfb2113144a, content=也不绝对是, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Fri Jun 16 05:48:30 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211132, encodeId=c10721113260, content=感谢分享!继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Jun 15 14:16:43 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211110, encodeId=36e621111049, content=所谓的,知识越丰富的人,越懂得养生, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KzSbouu359pgvYDCyAK5ibibTnaLHroP5qfFyvQgWlYFsrDGc3G5hialGftuXhkCvibDCf490Hey7JLB/0, createdBy=de201996268, createdName=月叔, createdTime=Thu Jun 15 13:05:52 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
    2017-06-16 lou.minghong

    也不绝对是

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1644562, encodeId=600e1644562d0, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Apr 11 14:30:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607649, encodeId=f52f160e6496a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jun 17 00:30:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211314, encodeId=cbfb2113144a, content=也不绝对是, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Fri Jun 16 05:48:30 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211132, encodeId=c10721113260, content=感谢分享!继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Jun 15 14:16:43 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211110, encodeId=36e621111049, content=所谓的,知识越丰富的人,越懂得养生, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KzSbouu359pgvYDCyAK5ibibTnaLHroP5qfFyvQgWlYFsrDGc3G5hialGftuXhkCvibDCf490Hey7JLB/0, createdBy=de201996268, createdName=月叔, createdTime=Thu Jun 15 13:05:52 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
    2017-06-15 明天会更好!

    感谢分享!继续关注!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1644562, encodeId=600e1644562d0, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Wed Apr 11 14:30:00 CST 2018, time=2018-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1607649, encodeId=f52f160e6496a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Jun 17 00:30:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211314, encodeId=cbfb2113144a, content=也不绝对是, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Fri Jun 16 05:48:30 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211132, encodeId=c10721113260, content=感谢分享!继续关注!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Thu Jun 15 14:16:43 CST 2017, time=2017-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=211110, encodeId=36e621111049, content=所谓的,知识越丰富的人,越懂得养生, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5KzSbouu359pgvYDCyAK5ibibTnaLHroP5qfFyvQgWlYFsrDGc3G5hialGftuXhkCvibDCf490Hey7JLB/0, createdBy=de201996268, createdName=月叔, createdTime=Thu Jun 15 13:05:52 CST 2017, time=2017-06-15, status=1, ipAttribution=)]
    2017-06-15 月叔

    所谓的,知识越丰富的人,越懂得养生

    0

相关资讯

JCEM:2型糖尿病患者质子泵抑制剂、肾病和心血管疾病有何关系?

由此可见,PPIs的使用与2型糖尿病患者经uACR评估的血管内皮功能持续的不利影响无关。然而,开始服用PPI与肾病恶化以及5年CVD风险增加之间的相关性,具有潜在的临床意义。

Circulation:儿童中添加糖和心血管疾病风险——美国心脏病协会科学声明

在饮食中添加糖会造成能量密集、营养价值低,并可增加肥胖、心血管疾病等发生风险。美国心脏病协会的科学声明中,编写组审查了添加糖对儿童的心血管健康影响的研究的现有科学证据,并对其进行了分级。相关报告发表在2017年5月《Circulation.》。

LANCET DIABETES ENDO:二甲双胍对I型糖尿病和心血管疾病有怎样的作用效果?

二甲双胍可减少I型成年糖尿病患者胰岛素用量,二甲双胍是否对糖尿病患者有其他效果?而对于心血管疾病是否也有疗效呢?

JCEM:DSST评分可提示糖尿病患者心血管疾病风险!

科学家经过研究已经发现糖尿病患者中患心血管疾病和认知功能障碍的风险增加。而近日发表在JCEM上的一篇事后流行病学分析研究对于CVD和认知功能的评分进行了深入研究,这项名为ACCORD-MIND的研究旨在调查2型糖尿病患者中认知功能的简单测量评分与CVD事件的发生和死亡率之间关联。以下是对这项研究的简单介绍。

Eur J Prev Cardiol:提高心血管疾病患者药物使用的依从性 从转换为聚合片治疗开始

心血管疾病一般需要长期服用药物。所以,探讨更优的药物方案一直是科学家的研究热点。2017年6月,发表在《Eur J Prev Cardiol》的一项由荷兰、爱尔兰、澳大利亚等国科学家进行的研究,考察了将心血管疾病患者不同治疗方案转换为固定剂量组合片的影响。

Eur J Prev Cardiol: 降低心血管疾病风险 体重正常的中老年人也要运动?

2017年6月,发表在《Eur J Prev Cardiol》的由荷兰科学家进行的鹿特丹研究表明,中老年人群中体育活动是比身体质量指数(BMI)影响心血管疾病(CVD)风险更重要的因素。